Related Experiment Videos
Familial hyperlipoproteinemia and gallstones
1University of Saskatchewan, Saskatoon.
Insights
Familial hyperlipoproteinemia patients frequently develop gallstones, particularly those with type IV. This study also found associations between gallstones and myocardial damage or sinus bradycardia in these patients.
Area of Science:
- Cardiology
- Metabolic Disorders
- Gastroenterology
Background:
- Familial hyperlipoproteinemia (FHLP) is a group of genetic disorders characterized by high levels of lipids in the blood.
- Gallstones (cholelithiasis) are a common condition, and their association with metabolic disorders is increasingly recognized.
Purpose of the Study:
- To investigate the prevalence of gallstones in patients with familial hyperlipoproteinemia.
- To explore potential correlations between gallstone formation and specific types of FHLP, patient demographics, and cardiovascular abnormalities.
Main Methods:
- Retrospective analysis of 108 patients diagnosed with familial hyperlipoproteinemia.
- Data collection included patient age, sex, FHLP type, presence of gallstones, serum triglyceride levels, and electrocardiographic findings.
Main Results:
- Overall, 42.6% of FHLP patients had gallstones.
- Type IV FHLP showed a 50% prevalence of gallstones, with a higher mean age in affected individuals.
- Patients with gallstones exhibited a higher incidence of myocardial damage and sinus bradycardia on electrocardiograms.
Conclusions:
- Gallstones are a significant comorbidity in familial hyperlipoproteinemia patients.
- Specific FHLP types and associated metabolic profiles may influence gallstone risk.
- The presence of gallstones in FHLP patients warrants consideration for cardiovascular health monitoring.
Abstract:
Of 108 patients with familial hyperlipoproteinemia between the ages of 22 and 85 years (mean, 55.1 years) 46 (42.6%) had cholelithiasis. Among the 53 patients with type II hyperlipoproteinemia 20 (38%) had gallstones; the male:female ratio was 1:2; the mean serum triglyceride value was significantly higher in those with gallstones. Among the 50 patients with type IV hyperlipoproteinemia 25 (50%) had gallstones; the male:female ratio was 1:1; the mean age was significantly higher in those with gallstones. Among the five patients with type V hyperlipoproteinemia one had gallstones. Electrocardiographic evidence of myocardial damage was present in 47 (44%) of the 108 patients; 18 (39%) of the 46 patients with gallstones showed such abnormalities, while 26 (24%) showed sinus bradycardia.